The University of Oulu is a multidisciplinary, international research university, with about 3,600 employees who produce new knowledge based on high-standards research and provide research based education to build a more sustainable, smarter, and more humane world. The University of Oulu community has about 17,000 people in total. Our northern scientific community operates globally and creates conditions for the emergence of innovations.
Applications are invited for a full-time
Postdoctoral Researcher in Molecular Cell Biology
The position is for a maximum of three years, starting at the earliest on 01.04.2025 in a multidisciplinary project “Next Generation Molecular Sensing” combining the expertise of five teams at the University of Oulu. The project is a collective effort of five research groups led by Profs. Caglar Elbuken, Aki Manninen, Jian-An Huang, Seppo Vainio, and Simo Saarakkala. The PIs in the consortium are leading experts in their respective fields and have complementary expertise ranging from nanotechnology, biosensors, optics, microfluidics, molecular cell biology and organoid technology. The postdoctoral researcher will be mainly supervised by Prof. Aki Manninen with an aim to develop cellular models and molecular strategies to validate and establish novel biosensor technologies. The position is part of a multidisciplinary project that will assemble a team of four researchers that will work in collaboration.
A multidisciplinary project that makes sense by modeling biology – our aim is to make every single molecule count
The main task of the hired researcher will be to develop novel biosensors by reconstituting biological signaling circuits in artificial engineered liposomes. This work involves protein engineering, production and reconstitution into lipid-enveloped vesicles. A good understanding of cellular signaling concepts is required. In addition to engineered liposome-based sensors, you will participate in testing and optimization of a minimally invasive single cell analysis platform. This nanotube-based novel technology utilizes ultrasensitive surface-enhanced Raman spectroscopy (SERS) to monitor cellular signaling events in live cells. Your responsibility will be to develop cellular models to help to optimize the technology and to tune the specificity of the read-outs.
You will work together with our multinational team and will have access to advanced cell culture models including patient-derived organoids, advanced microscopy techniques, ample tools for viral CRISPR/Cas9-based genomic engineering as well as excellent facilities for molecular cell biology and protein biochemistry work.
The position is full-time and fixed-term for maximum of 3 years as of 01.04.2025 or as soon as possible thereafter.
The salary will be based on the levels 5-6 of the demand level chart for teaching and research staff of Finnish universities. In addition, a salary component based on personal work performance will be paid (maximum of 50 % of the job-specific component). Starting gross salary will be approx. 3500-4300 € per month (before taxes) depending on qualifications and experience.
A trial period of 6 months is applied in the position.
Interested? If yes, please apply by 22nd March 2025 (23:59 Finnish local time) through our recruitment system.
The application should be written in English and include the following:
The eligible applicants fitting best in the profile expected for the position will be invited to an on-site or remote interview. All applicants will be notified during the selection process.
We welcome applicants from all backgrounds, such as people of different ages, genders, and lingual, cultural, or minority groups.
If you have any further questions, please contact Prof. Aki Manninen, email: aki.manninen(at)oulu.fi
Type of employment | Temporary position over 6 months |
---|---|
Contract type | Full time |
Number of positions | 1 |
Full-time equivalent | 100% |
City | Oulu |
County | Pohjois-Pohjanmaa |
Country | Finland |
Reference number | 2025/154 |
Contact |
|
Published | 18.Feb.2025 |
Last application date | 22.Mar.2025 |